Characterization of different soluble TNF receptor (TNFR8O) derivatives: Positive influence of the intracellular domain on receptor/ligand interaction and TNF neutralization capacity

被引:16
作者
Moosmayer, D
Wajant, H
Gerlach, E
Schmidt, M
Brocks, B
Pfizenmaier, K
机构
[1] Institute of Cell Biology and Immunology, University of Stuttgart, D-70569 Stuttgart
关键词
D O I
10.1089/jir.1996.16.471
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Different soluble human TNFR80 derivatives, a solubilized form of the complete TNFR80, the TNFR80 extracellular domain, a secretory TNFR80 mutant (TR80TM(-)) with a deleted transmembrane region, and a TNFR80 immunoadhesin were produced in insect cells and characterized side by side with a recombinant human TNFR60 extracellular domain with respect to TNF binding affinity and neutralization of TNF bioactivity. The construct TR80TM(-) and the solubilized complete TNFR80 revealed a similar TNF binding and neutralization capacity, which was superior to the monovalent TNFR80 extracellular domain and comparable to the bivalent TNFR80 immunoadhesin, already known as a potent TNF antagonist, Determination of ligand off rate constants of the various receptor constructs by surface plasmon resonance revealed a correlation of low off rates with a high TNF neutralization capacity, We propose that the high TNF binding and neutralization capacity of the solubilized complete TNFR80 and TR80TM(-) in comparison with the monovalent extracellular TNR80 domain is due to a noncovalent self-aggregation of the receptors via their intracellular domain. This finding suggests that efficient soluble TNF antagonists can be derived from TNFR themselves without the need of construction of TNFR Ig Fc fusion proteins.
引用
收藏
页码:471 / 477
页数:7
相关论文
共 33 条
[11]  
ENGELMANN H, 1990, J BIOL CHEM, V265, P1531
[12]   PROTECTIVE EFFECT OF 55-KD BUT NOT 75-KD SOLUBLE TUMOR-NECROSIS-FACTOR RECEPTOR IMMUNOGLOBULIN-G FUSION PROTEINS IN AN ANIMAL-MODEL OF GRAM-NEGATIVE SEPSIS [J].
EVANS, TJ ;
MOYES, D ;
CARPENTER, A ;
MARTIN, R ;
LOETSCHER, H ;
LESSLAUER, W ;
COHEN, J .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 180 (06) :2173-2179
[13]   THE TRANSMEMBRANE FORM OF TUMOR-NECROSIS-FACTOR IS THE PRIME ACTIVATING LIGAND OF THE 80 KDA TUMOR-NECROSIS-FACTOR RECEPTOR [J].
GRELL, M ;
DOUNI, E ;
WAJANT, H ;
LOHDEN, M ;
CLAUSS, M ;
MAXEINER, B ;
GEORGOPOULOS, S ;
LESSLAUER, W ;
KOLLIAS, G ;
PFIZENMAIER, K ;
SCHEURICH, P .
CELL, 1995, 83 (05) :793-802
[14]   INHIBITION OF LIGAND-BINDING AND ANTIPROLIFERATIVE EFFECTS OF TUMOR-NECROSIS-FACTOR AND LYMPHOTOXIN BY SOLUBLE FORMS OF RECOMBINANT P60 AND P80 RECEPTORS [J].
HIGUCHI, M ;
AGGARWAL, BB .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1992, 182 (02) :638-643
[15]   SOLUBLE TUMOR-NECROSIS-FACTOR RECEPTOR - INHIBITION OF HUMAN-IMMUNODEFICIENCY-VIRUS ACTIVATION [J].
HOWARD, OMZ ;
CLOUSE, KA ;
SMITH, C ;
GOODWIN, RG ;
FARRAR, WL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (06) :2335-2339
[16]   TRANSGENIC MICE EXPRESSING HUMAN TUMOR-NECROSIS-FACTOR - A PREDICTIVE GENETIC MODEL OF ARTHRITIS [J].
KEFFER, J ;
PROBERT, L ;
CAZLARIS, H ;
GEORGOPOULOS, S ;
KASLARIS, E ;
KIOUSSIS, D ;
KOLLIAS, G .
EMBO JOURNAL, 1991, 10 (13) :4025-4031
[17]   RECOMBINANT SOLUBLE TUMOR-NECROSIS-FACTOR RECEPTOR PROTEINS PROTECT MICE FROM LIPOPOLYSACCHARIDE-INDUCED LETHALITY [J].
LESSLAUER, W ;
TABUCHI, H ;
GENTZ, R ;
BROCKHAUS, M ;
SCHLAEGER, EJ ;
GRAU, G ;
PIGUET, PF ;
POINTAIRE, P ;
VASSALLI, P ;
LOETSCHER, H .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1991, 21 (11) :2883-2886
[18]  
LOETSCHER H, 1991, J BIOL CHEM, V266, P18324
[19]  
MOHLER KM, 1993, J IMMUNOL, V151, P1548
[20]  
MOOSMAYER D, 1994, LYMPHOKINE CYTOK RES, V13, P295